[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100529878":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":29,"locations":37,"responsibleParty":54,"collaborators":56,"id":60,"slug":18,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":64,"acronym":18,"eligibilityCriteria":65,"healthyVolunteers":61,"sex":66,"minAge":67,"maxAge":18,"enrollmentInfo":68,"targetDuration":18,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":77,"overallStatus":39,"whyStopped":18,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"University of California, San Francisco","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention","EXPERIMENTAL","In addition to standard HCV results disclosure for the comparator arm, intervention participants will have two counseling sessions:\n\nSession 1: Immediately after HCV results disclosure, a staff-facilitated session with the index to (1) Establish HCV Treatment Goals, fostering commitment, and (2) Engage the Injecting Partner, identifying ways to support treatment initiation.\n\nSession 2: One week later, involving both the index and injecting partner, to (1) Enhance Partner Support with specific strategies for HCV treatment initiation and (2) Collaborative Navigation Mapping, using a \"navigation map\" tool. By Session 2's end, both will have a completed navigation map, a visual guide for the HCV treatment journey.\n\nBoth sessions stress communication and dyadic coordination. The \"navigation map\" tool ensures a personalized plan for the index's treatment initiation and the partner's supportive navigator role.",[13],"Behavioral: Partner Navigation Intervention",{"label":15,"type":16,"description":17,"interventionNames":18},"Control","NO_INTERVENTION","Standard of care HCV disclosure. This staff-facilitated session follows the California HIV\u002FHCV test counselor certification protocol with the Index alone.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"BEHAVIORAL","Partner Navigation Intervention","A two-session, disclosure counselor-led, behavioral intervention to enable the injecting partner to support and navigate the adult PWID to start HCV treatment.",[9],[26],{"name":27,"affiliation":5,"role":28},"Meghan D Morris, MPH, PhD","PRINCIPAL_INVESTIGATOR",[30,34],{"name":27,"role":31,"phone":32,"phoneExt":18,"email":33},"CONTACT","415-574-0651","meghan.morris@ucsf.edu",{"name":35,"role":31,"phone":18,"phoneExt":18,"email":36},"Claire McDonell, MS","claire.mcdonell@ucsf.edu",[38],{"facility":5,"status":39,"city":40,"state":41,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"RECRUITING","San Francisco","California","94158","United States","US",{"type":46,"coordinates":47},"Point",[48,49],-122.41942,37.77493,{"lat":49,"lon":48},[52,53],{"name":27,"role":31,"phone":18,"phoneExt":18,"email":33},{"name":35,"role":31,"phone":18,"phoneExt":18,"email":36},{"type":55,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR",[57],{"name":58,"class":59},"National Institute on Drug Abuse (NIDA)","NIH","100529878",false,"NCT06179498","Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs","A Randomized Trial to Test the Efficacy of a Partner Navigation Intervention for HCV Treatment Among Young Adult People Who Inject Drugs","Inclusion Criteria:\n\n* Self report injecting drugs in the past month\n* Self report a primary injecting partner (currently inject drugs together)\n* HCV infection identified at partnering community-based clinical site","ALL","18 Years",{"count":69,"type":70},500,"ESTIMATED","INTERVENTIONAL",[73],"NA","The Partner Navigation Intervention Study is a randomized controlled study (RCT) to assess the efficacy and mechanism of action of the first behavioral intervention to increase hepatitis C (HCV) treatment initiation among adult people who inject drugs (PWID).",[76],"Hepatitis C",[78],"Young people who inject drugs","2025-03-11",{"date":81,"type":82},"2025-03-13","ACTUAL",{"date":84,"type":82},"2024-03-25",{"date":86,"type":70},"2027-06-01",{"name":5,"class":6},1]